Manufacturing

Review of SUT Adoption in Biopharma Manufacturing

The evolution of therapeutic modalities drives the adoption of single-use technologies.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Automating the Future of Fill/Finish

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

MilliporeSigma Opens Two New GMP Manufacturing Sites in Germany for mRNA Production

September 28, 2023

With the two new GMP-grade mRNA manufacturing sites in Germany, MilliporeSigma can now offer fully integrated mRNA services.

Dyadic and bYoRNA Collaborate on Production of mRNA

September 26, 2023

The companies plan on targeting the production of abundant, low-cost messenger RNA from C1-cells.

Genentech Forms Collaboration with PeptiDream for Peptide-Radioisotope Drug Conjugates

September 26, 2023

Under a new pact, Genentech and PeptiDream will collaborate to discover and develop novel peptide-radioisotope drug conjugates.

Novo Nordisk Foundation to Establish New Cell Therapy Manufacturing Facility in Denmark

September 25, 2023

The Novo Nordisk Foundation will invest up to DKK 950 million (€127 million, US$136 million) in a new cell therapy manufacturing facility in Lyngby, Denmark.

FUJIFILM Diosynth Biotechnologies Completes New Viral Vector Gene Therapy Manufacturing Facility in UK

September 21, 2023

FUJIFILM Diosynth Biotechnologies has finished its new viral vector gene therapy manufacturing facility in Darlington, United Kingdom.

Improving Facilities in an Efficient Manner (PDA/FDA Joint Regulatory Conference 2023)

September 21, 2023

Maik Jornitz, Principal Consultant, BioProcess Resources LLC, discusses how to upgrade facilities in an efficient manner and other highlights from his presentation.

Continuous Manufacturing is Here to Stay (PDA/FDA Joint Regulatory Conference 2023)

September 20, 2023

Kelley Burridge, PhD, Product Quality Team Leader, OBP, OPQ, CDER, U.S. FDA, discusses the importance of continuous manufacturing for the future.

Samsung Biologics Expands Strategic Manufacturing Agreement with Bristol Myers Squibb

September 20, 2023

Samsung Biologics and Bristol Myers Squibb have further expanded their strategic manufacturing agreement to include the large-scale manufacture of an antibody cancer drug substance.

The Impact of Advanced Manufacturing Technology (PDA/FDA Joint Regulatory Conference 2023)

September 19, 2023

Kelley Burridge, PhD, Product Quality Team Leader, OBP, OPQ, CDER, U.S. FDA, discusses how advanced manufacturing technology can improve things such as cost and efficiency.

Webcasts

High Performance Solutions for Dpi Delivery: New Formulation and Device Platforms

September 19, 2023

Webinar Date/Time: Wed, Oct 4, 2023 - 11:00 am EDT | 4:00 pm GMT | 5:00 pm CEST | 8:00 am PDT